Biomarkers in Drug Hypersensitivity
Biomarkers, especially those based on pharmacogenomics testing, have proved to be extremely useful for type A adverse drug reactions. Clinical practice guidelines based on biomarker testing are presently being developed and updated for type A adverse drug reactions. In contrast, little attention has...
Enregistré dans:
Auteur principal: | Emanuela Corsini (auth) |
---|---|
Autres auteurs: | Silvia Selinski (auth), Jose A. G. Agundez (auth), Elena Garcia-Martin (auth), Klaus Golka (auth) |
Format: | Électronique Chapitre de livre |
Langue: | anglais |
Publié: |
Frontiers Media SA
2017
|
Collection: | Frontiers Research Topics
|
Sujets: | |
Accès en ligne: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape
par: Neal M. Davies (Ed.)
Publié: (2018) -
Novel Targets and Biomarkers in Solid Tumors
Publié: (2020) -
Novel Targets and Biomarkers in Solid Tumors, 2nd Edition
Publié: (2020) -
Chapter Challenges and New Frontiers in the Paediatric Drug Discovery and Development
par: Bonifazi, Donato
Publié: (2020) -
Chapter Challenges and New Frontiers in the Paediatric Drug Discovery and Development
par: Bonifazi, Donato
Publié: (2020)